India's drug regulator said on Thursday that it had inspected Marion Biotech's production facility and promised more action based on the probe report after the company's cough syrup was linked to the death of 18 children in Uzbekistan. The drug regulator reviewed the company's Noida facility in the Uttar Pradesh state and is in regular touch with its Uzbekistan counterpart, the Indian health ministry said in a statement.
► Subscribe to The Economic Times for the latest video updates. It's free! - [ Ссылка ]
► More Videos @ ETTV - [ Ссылка ]
► [ Ссылка ]
► For business news on the go, download ET app:
[ Ссылка ]
Follow ET on:
► Facebook - [ Ссылка ]
► Twitter - [ Ссылка ]
► LinkedIn - [ Ссылка ]
► Instagram - [ Ссылка ]
► Flipboard - [ Ссылка ]
#news #latestnews #economictimes #ET #TheEconomicTimes #businessnews
